Trade EDSA anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Edesa Biotech, Inc. Common Shares (EDSA) is trading at US$4.73, down 0.63% today as of Sep 4, 16:00 EDT. The company has a market capitalisation of US$42.71M. Over the past 52 weeks, EDSA has traded between US$0.72 and US$20.32. On Syfe you can trade EDSA with $0 commission and add it to your watchlist.
| Previous close | US$4.76 |
|---|---|
| Market cap | US$42.71M |
| 52-week range | US$0.72 – US$20.32 |
| Volume | 36.33K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Edesa Biotech, Inc. Common Shares
Edesa Biotech, Inc. is a biopharmaceutical company, which focuses on acquisition, development, and commercialization of drug candidates for medical dermatology and respiratory diseases. Its clinical studies include EB05 for Acute Respiratory Distress Syndrome (ARDS), EB07 for systemic sclerosis (SSc), EB01 for chronic Allergic Contact Dermatitis (ACD), and EB06 for vitiligo. The company was founded by Pardeep Nijhawan on June 12, 2007 and is headquartered in Markham, Canada.
Year: 2010
Sector Update: Healthcare Stocks Gain Friday Afternoon
Jun 5, 5:50 PM · MT Newswires
Top Midday Stories: Lululemon Down After Fiscal Q1 Results; Amazon Engineers Criticize AI Spending; Hoffman to Exit Microsoft Board
Jun 5, 4:07 PM · MT Newswires
Edesa Biotech Says Paridiprubart Linked to Lower Risk of Death in Acute Kidney Injury Patients
Jun 5, 2:12 PM · MT Newswires
Stay on top of EDSA
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
